Amgen

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Amgen (AMGN) Stock Dips While Market Gains: Key Facts (öffnet in neuem Tab)

  uk.finance.yahoo.com · 01.10.2026

• Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know (öffnet in neuem Tab)

  TradingKey · 01.10.2026

• 
  2 Profitable Stocks with Exciting Potential and 1 We Find Risky (öffnet in neuem Tab)

  StockStory · 01.10.2026

• Is Amgen (AMGN) Undervalued Following Its Phase 3 Sjögren's Disease Trial Update? (öffnet in neuem Tab)

  Simply Wall Street · 30.09.2026

• Amgen Research Offers Clue to Weight-Loss Drug Paradox (öffnet in neuem Tab)

  Bloomberg.com · 30.09.2026

• Amgen Readies Daxdilimab For Phase III In Discoid Lupus After Mid-Stage Trial (öffnet in neuem Tab)

  insights.citeline.com · 30.09.2026

• Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody (öffnet in neuem Tab)

  Fierce Biotech · 30.09.2026

• Amgen Inc. stock outperforms competitors on strong trading day (öffnet in neuem Tab)

  marketwatch.com · 29.09.2026

• Is Eli Lilly Stock a Good Fit For Your Portfolio Risk? (öffnet in neuem Tab)

  Trefis · 29.09.2026

• BMS’s Opdivo patent suit against Amgen adds to eventful 2026 for biosimilar spats (öffnet in neuem Tab)

  IAM Media · 29.09.2026

• Management Raised the Bar For Eli Lilly Stock; Does The Chart Agree? (öffnet in neuem Tab)

  Trefis · 29.09.2026

• Why Amgen’s 6% Dividend Raise Masks a Tougher Road Ahead (öffnet in neuem Tab)

  24/7 Wall St. · 29.09.2026

• Amgen-Produced Systemic Treatment for Sjogrens Disease Yields Positive Results (öffnet in neuem Tab)

  Labroots · 29.09.2026

• Amgen (AMGN) Has a New Growth Opportunity. But How Much Is It Really Worth? (öffnet in neuem Tab)

  Insider Monkey · 29.09.2026

• Amgen (AMGN), What Is Behind The Fresh Attention? (öffnet in neuem Tab)

  Simply Wall St. · 29.09.2026

• Can Roche’s Latest Obesity Drug Results Help it Challenge Eli Lilly and Novo Nordisk? (öffnet in neuem Tab)

  Insider Monkey · 28.09.2026

• Scotiabank Raises Amgen Price Target to $500 From $450, Sector Outperform Rating Kept (öffnet in neuem Tab)

  Yahoo Finance · 28.09.2026

• Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook (öffnet in neuem Tab)

  TradingKey · 28.09.2026

• Take the Zacks Approach to Beat the Markets: Bloom Energy, Microsoft & Amgen in Focus (öffnet in neuem Tab)

  Zacks · 28.09.2026

• Why Amgen’s Pipeline Just Got More Interesting (öffnet in neuem Tab)

  Insider Monkey · 27.09.2026

• Amgen (AMGN) Sells its Deerfield Campus for $151 Million and Leases it Back (öffnet in neuem Tab)

  Insider Monkey · 27.09.2026

• Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (öffnet in neuem Tab)

  Barrons.com · 27.09.2026

• 2 Healthcare Stocks That Just Delivered Great News for Investors (öffnet in neuem Tab)

  Motley Fool · 26.09.2026

• How Phase 3 Sjögren’s Results At Amgen (AMGN) Has Changed Its Investment Story (öffnet in neuem Tab)

  Simply Wall Street · 26.09.2026

• Amgen’s Deerfield office campus sold to Mesirow for $151M in sale-leaseback deal (öffnet in neuem Tab)

  The Real Deal · 25.09.2026

• Amgen (AMGN) Rises Higher Than Market: Key Facts (öffnet in neuem Tab)

  Yahoo Finance · 25.09.2026

• Is LLY Stock Cheaper Than It Looks? (öffnet in neuem Tab)

  Trefis · 25.09.2026

• Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (öffnet in neuem Tab)

  Zacks · 25.09.2026

• The Peptide Boom That Isn’t About Your Muscles (öffnet in neuem Tab)

  The Wall Street Journal · 25.09.2026

• How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients (öffnet in neuem Tab)

  Simply Wall St. · 25.09.2026